IMMX vs. SPMO

Last updated Aug 1, 2026

IMMX (Immix Biopharma, Inc.) is a stock, while SPMO (Invesco S&P 500 Momentum ETF) is Momentum fund tracking the S&P 500 Momentum Index. Over the past 3 years, IMMX returned 59.51%/yr vs 37.36%/yr for SPMO. Their 0.20 correlation means their historical movements had little consistent relationship.

Performance

IMMX vs. SPMO - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Immix Biopharma, Inc. (IMMX) and Invesco S&P 500 Momentum ETF (SPMO). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, IMMX achieves a 59.08% return, which is significantly higher than SPMO's 21.07% return.

IMMX

• 1D: -2.69%
• 1M: -19.54%
• 6M: 42.71%
• YTD: 59.08%
• 1Y: 213.96%
• 3Y*: 59.51%
• 5Y*: —
• 10Y*: —
• ALL TIME*: 11.65%

SPMO

• 1D: 0.29%
• 1M: -4.64%
• 6M: 20.51%
• YTD: 21.07%
• 1Y: 28.09%
• 3Y*: 37.36%
• 5Y*: 20.21%
• 10Y*: 19.57%
• ALL TIME*: 18.93%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison

Position	Avg. Volume Value (2W)	Avg. Volume Value (1M)	Avg. Volume Value (3M)
IMMX Immix Biopharma, Inc.	$17.08M	$18.10M	$16.58M
SPMO Invesco S&P 500 Momentum ETF	$331.54M	$346.70M	$350.59M

IMMX vs. SPMO - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021
IMMX Immix Biopharma, Inc.	59.08%	137.73%	-68.21%	202.18%	-35.67%	-28.80%
SPMO Invesco S&P 500 Momentum ETF	21.07%	26.58%	45.82%	17.56%	-10.45%	0.38%

Correlation

The correlation between IMMX and SPMO is 0.18, which is low. Their historical price movements had little consistent relationship.

	Correlation
Correlation (1Y) Focuses on recent behavior, but can change the most.	0.18
Correlation (3Y) Balances recent behavior with more history.	0.20
Correlation (All Time) Calculated using the full available price history since Dec 16, 2021	0.20

Return for Risk

IMMX vs. SPMO — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

IMMX

IMMX Risk / Return Rank: 92
IMMX Sharpe Ratio Rank: 95
IMMX Sortino Ratio Rank: 91
IMMX Omega Ratio Rank: 87
IMMX Calmar Ratio Rank: 95
IMMX Martin Ratio Rank: 92

SPMO

SPMO Risk / Return Rank: 46
SPMO Sharpe Ratio Rank: 43
SPMO Sortino Ratio Rank: 43
SPMO Omega Ratio Rank: 45
SPMO Calmar Ratio Rank: 46
SPMO Martin Ratio Rank: 51

The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

IMMX vs. SPMO - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Immix Biopharma, Inc. (IMMX) and Invesco S&P 500 Momentum ETF (SPMO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	IMMX	SPMO	Difference
Sharpe ratio: Return per unit of total volatility	2.39	1.07	+1.33
Sortino ratio: Return per unit of downside risk	2.88	1.56	+1.32
Omega ratio: Gain probability vs. loss probability	1.33	1.21	+0.13
Calmar ratio: Return relative to maximum drawdown	5.20	1.63	+3.57
Martin ratio: Return relative to average drawdown	11.08	5.93	+5.14

IMMX vs. SPMO - Sharpe Ratio Comparison

The current IMMX Sharpe Ratio is 2.39, which is higher than the SPMO Sharpe Ratio of 1.07. The chart below compares the historical Sharpe Ratios of IMMX and SPMO, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

IMMX vs. SPMO - Drawdown Comparison

The maximum IMMX drawdown since its inception was -88.89%, which is greater than SPMO's maximum drawdown of -30.95%. Use the drawdown chart below to compare losses from any high point for IMMX and SPMO.

Drawdown Indicators

	IMMX	SPMO	Difference
Max Drawdown Largest peak-to-trough decline	-88.89%	-30.95%	-57.94%
Max Drawdown (1Y) Largest decline over 1 year	-39.84%	-15.64%	-24.20%
Max Drawdown (3Y) Largest decline over 3 years	-81.57%	-20.13%	-61.44%
Max Drawdown (5Y) Largest decline over 5 years	—	-22.74%	—
Max Drawdown (10Y) Largest decline over 10 years	—	-30.95%	—
Current Drawdown Current decline from peak	-30.78%	-11.03%	-19.75%
Average Drawdown Average peak-to-trough decline	-57.44%	-4.62%	-52.82%
Ulcer Index Depth and duration of drawdowns from previous peaks	18.68%	4.29%	+14.39%

Volatility

IMMX vs. SPMO - Volatility Comparison

Immix Biopharma, Inc. (IMMX) has a higher volatility of 28.24% compared to Invesco S&P 500 Momentum ETF (SPMO) at 10.53%. This indicates that IMMX's price experiences larger fluctuations and is considered to be riskier than SPMO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	IMMX	SPMO	Difference
Volatility (1M) Calculated over the trailing 1-month period	28.24%	10.53%	+17.71%
Volatility (6M) Calculated over the trailing 6-month period	56.95%	21.52%	+35.43%
Volatility (1Y) Calculated over the trailing 1-year period	86.62%	23.90%	+62.72%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	109.23%	20.60%	+88.63%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	109.23%	20.92%	+88.31%

Dividends

IMMX vs. SPMO - Dividend Comparison

IMMX has not paid dividends to shareholders, while SPMO's dividend yield for the trailing twelve months is around 0.73%.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
IMMX Immix Biopharma, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
SPMO Invesco S&P 500 Momentum ETF	0.73%	0.73%	0.48%	1.63%	1.66%	0.52%	1.27%	1.39%	1.05%	0.77%	1.94%	0.36%

Frequently Asked Questions

Can I hold both IMMX and SPMO in my portfolio?

IMMX and SPMO have a correlation of 0.18, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, IMMX or SPMO?

IMMX has higher volatility (28.24%) compared to SPMO (10.53%). In terms of maximum drawdown, IMMX dropped -88.89% vs SPMO's -30.95%.

Which has better risk-adjusted returns?

IMMX currently has the higher Sharpe Ratio (2.39 vs 1.07), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.